PARP1 and ovarian carcinoma: We searched PubMed and Web of Science up to February 2022 with the search terms (“PARP inhibitors” OR “PARPi” OR “poly ADP-ribose polymerase inhibitors”) AND (“antiangiogenics”) AND (“Platinum-Resistant Ovarian Cancer” OR “PROC” OR “platinum-resistant recurrent ovarian cancer”).